SERPINF2 (Stromab Biosimilar) Recombinant Monoclonal Antibody
-
貨號:CSB-RA021085MB2HU
-
規(guī)格:¥83486
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:SERPINF2 (Stromab Biosimilar Antibody)重組單克隆抗體是一款專為科研用途設(shè)計的生物制劑。該產(chǎn)品以SERPINF2為靶點,通過重組DNA技術(shù)在哺乳動物細胞表達系統(tǒng)中制備,具有高純度、高特異性的特點。其核心功能在于精準識別并結(jié)合SERPINF2蛋白,為研究SERPINF2在生理及病理過程中的分子機制提供可靠工具。 在科研應(yīng)用中,該抗體可廣泛用于蛋白質(zhì)印跡、酶聯(lián)免疫吸附試驗(ELISA)某些實驗技術(shù),助力研究者探索SERPINF2在細胞信號通路調(diào)控、疾病發(fā)生發(fā)展中的作用。產(chǎn)品經(jīng)過嚴格的質(zhì)量控制,確保批次間的穩(wěn)定性和一致性,能有效降低實驗誤差,提升研究數(shù)據(jù)的可靠性。 此外,該重組單克隆抗體的設(shè)計充分考慮科研需求,提供靈活的劑型選擇,可滿足不同實驗規(guī)模的用量要求。其高度的靶向結(jié)合能力使得在復(fù)雜生物樣本中也能實現(xiàn)對SERPINF2的精準檢測與分析,為深入揭示相關(guān)疾病的分子機制、開發(fā)新型治療策略提供重要的實驗基礎(chǔ)。作為科研工具,該產(chǎn)品為生命科學(xué)領(lǐng)域的研究者提供了有力支持,推動SERPINF2相關(guān)基礎(chǔ)研究及轉(zhuǎn)化醫(yī)學(xué)研究的進展。
-
Uniprot No.:
-
基因名:
-
別名:CSL301 research-grade biosimilar; CSL 301 research-grade biosimilar; CSL-301 research-grade biosimilar; DS-9231 research-grade biosimilar; TS23 research-grade biosimilar; TS 23 research-grade biosimilar; TS-23 research-grade biosimilar ;SERPINF2 antibody; AAP antibody; PLI antibody; Alpha-2-antiplasmin antibody; Alpha-2-AP antibody; Alpha-2-plasmin inhibitor antibody; Alpha-2-PI antibody; Serpin F2 antibody
-
反應(yīng)種屬:Human
-
免疫原:Recombinant Human SERPINF2 protein
-
免疫原種屬:Homo sapiens (Human)
-
標記方式:Non-conjugated
-
克隆類型:Monoclonal
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:0.01M PBS,pH7.4
-
產(chǎn)品提供形式:Liquid
-
應(yīng)用說明:Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity?> 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method. -
儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:3-4 weeks
-
用途:It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.
相關(guān)產(chǎn)品
靶點詳情
-
功能:Serine protease inhibitor. The major targets of this inhibitor are plasmin and trypsin, but it also inactivates matriptase-3/TMPRSS7 and chymotrypsin.
-
基因功能參考文獻:
- alpha2AP has a profibrotic effect probably not by the action as a plasmin inhibitor, and the blocking of alpha2AP exerts an antifibrotic effect in humans and mice with systemic sclerosis PMID: 26743600
- This review presents recent findings regarding the main aspects of the natural heterogeneity of A2AP with particular focus on the functional and possible clinical implications. [review] PMID: 26626994
- Possession of the alpha2AP 407Lys allele was negatively associated with AAA, and thus changes in alpha2AP may affect aneurysm growth and development. PMID: 25065555
- Changes in plasma A2AP are associated with cardiovascular disease event presentation. PMID: 26088309
- A significant correlation was found between soluble fibroblast activation protein levels and alpha2-antiplasmin cleavage in coronary thrombosis. PMID: 25464232
- increased N-terminal cleavage of alpha2AP may have a role in liver cirrhosis PMID: 24034420
- FXIII-A has a functional role through exposure on the activated platelet membrane where it exerts antifibrinolytic function by cross-linking alpha2AP to fibrin PMID: 25331118
- Data suggest serum A2AP (SERPINF2) level can serve as biomarker for diabetic retinopathy; levels of A2AP (but not fibrinogen, plasminogen, or plasminogen activator inhibitor 1) are up-regulated in hyperglycemic type 1 diabetes with retinopathy. PMID: 24818165
- protective mediator during gram-negative (pneumo)sepsis, limiting bacterial growth, inflammation, tissue injury, and coagulation PMID: 23992406
- Study revealed that plasmin was present in tumor tissue, and that it was responsible for processing progalanin to galanin(1-20) in the extracellular environment. PMID: 21707521
- Data suggest that decreased amounts of alpha2-plasmin inhibitor in plasma vs serum ex vivo may reflect reduced factor XIII (FXIII) in vivo; thus, plasma vs serum alpha2-plasmin inhibitor may be useful diagnostic marker for severe FXIII deficiency. PMID: 22205503
- fibrinolysis is enhanced by inhibiting enzymatic cleavage of precursor alpha2-antiplasmin PMID: 21251197
- Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption. PMID: 21486949
- Levels of free full-length alpha2AP were decreased in myocardial infarction (MI); the percentage of C-terminally cleaved alpha2AP was unaltered, and Arg407Lys did not influence alpha2AP levels or MI risk. PMID: 21505192
- the antifibrinolytic function of FXIII is independent of fibrin-fibrin cross-linking and is expressed exclusively through alphaAP. PMID: 21471521
- ADAMTS13 inactivation by plasmin as a potential cause of thrombotic thrombocytopenic purpura PMID: 20553378
- deficiency in patients with Philadelphia chromosome-positive haematologic cancer receiving imatinib mesylate PMID: 19492163
- OPN is highly susceptible to cleavage near its integrin-binding motifs, and the protein is a novel substrate for plasmin and cathepsin D PMID: 20071328
- FXIIIa substrate, A2AP, sequences suggests that the residue located two positions beyond the reactive glutamine is not conserved. this position makes important contributions to effective FXIIIa-A2AP interactions PMID: 19691486
- Multiple Lys residues within alpha 2-antiplasmin contribute, perhaps in a zipper-like fashion, to its binding to the in-tandem, multikringle array that configures the plasmin heavy chain. PMID: 12549929
- Alpha2-antiplasmin has an important role in acute pulmonary embolism PMID: 12911586
- the Arg6Trp polymorphism may play a significant role in governing the long-term deposition/removal of intravascular fibrin PMID: 17317851
- Fibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrate PMID: 17883703
- Hydroxyethyl starch (HES) dilution enhances fibrinolysis by diminishing alpha2-antiplasmin-plasmin interactions. PMID: 17890952
- Sequencing analysis revealed the presence of two alpha2-PI gene variations, both in the second half of exon 10: a frameshift mutation and a G to A transition at nucleotide 11337 in codon 407. PMID: 17961166
- Thrombin activatable fibrinolysis inhibitor and alpha(2)-antiplasmin are not markers for recanalization in patients with ischemic stroke treated with recombinant tissue-type plasminogen activator. PMID: 18048863
- Plasmin in nephrotic urine activates the epithelial sodium channel PMID: 19073825
顯示更多
收起更多
-
相關(guān)疾?。?/div>Alpha-2-plasmin inhibitor deficiency (APLID)亞細胞定位:Secreted.蛋白家族:Serpin family組織特異性:Expressed by the liver and secreted in plasma.數(shù)據(jù)庫鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-















